Showing items 101–200
PD-L1 SPECIFIC ANTIBODIES
Application RU-2756236-C2
Russian Federation
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11117948-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11117949-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11117950-B2
United States of America
Antibodies to human programmed death receptor PD-1
Grant US-11117961-B2
United States of America
Activatable anti-CTLA-4 antibodies and uses thereof
Grant US-11117968-B2
United States of America
Anti PD-L1 antibodies
Grant US-11111300-B2
United States of America
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11096988-B2
United States of America
Treatment of Hodgkin lymphoma using an anti-PD-1 antibody
Grant US-11083790-B2
United States of America
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR; ANTIBODY THAT BINDS TO…
Application EP-3858859-A1
European Patent Office
CD80 variant immunomodulatory proteins and uses thereof
Grant US-11078282-B2
United States of America
Treatment of renal cell carcinoma
Grant US-11078278-B2
United States of America
Treatment of lung cancer using a combination of an anti-PD-1 antibody and an anti-CTLA-4…
Grant US-11072657-B2
United States of America
Anti-PD-1 antibodies
Grant US-11072659-B2
United States of America
ANTIBODIES TO PD-1 AND COMPOSITIONS
Application RU-2750675-C1
Russian Federation
COMBINATION THERAPY FOR CANCER
Application EP-3835323-A1
European Patent Office
Selective histone deacetylase inhibitors for the treatment of human disease
Grant US-11034667-B2
United States of America
Anti-PD-1 antibodies and compositions
Grant US-11034765-B2
United States of America
Antibody molecules for cancer treatment
Grant US-11028169-B2
United States of America
Antibodies to programmed cell death protein 1
Grant US-11021540-B2
United States of America
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-11013802-B2
United States of America
Antibody molecules to TIM-3 and uses thereof
Grant US-10981990-B2
United States of America
Anti PD-1 antibodies
Grant US-10981994-B2
United States of America
Methods of treating epithelioid cell tumors comprising administering a composition…
Grant US-10973806-B2
United States of America
Anti-PD-1 antibodies and uses thereof
Grant US-10973915-B2
United States of America
PD-1 antibodies
Grant US-10913801-B2
United States of America
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-10912831-B1
United States of America
ICOS ligand variant immunomodulatory proteins and uses thereof
Grant US-10882914-B2
United States of America
Combination of a PD-1 antagonist and a RAF inhibitor for treating cancer
Grant US-10864203-B2
United States of America
Antibodies specific to glycosylated PD-1 and methods of use thereof
Grant US-10858432-B2
United States of America
Antibodies specific to glycosylated PD-L1 and methods of use thereof
Grant US-10836827-B2
United States of America
MULTIVALENT D-PEPTIDIC COMPOUNDS FOR TARGET PROTEINS
Application WO-2020198075-A2
World Intellectual Property Organisation (WIPO)
Antibody molecules to PD-1 and uses thereof
Grant US-10752687-B2
United States of America
Antibody molecules to LAG-3 and uses thereof
Grant US-10711060-B2
United States of America
Methods for treating neurodegenerative diseases using anti-PD-L1 antibodies
Grant US-10711059-B2
United States of America
Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies
Grant US-10683347-B2
United States of America
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
Grant US-10668152-B2
United States of America
ANTI-MERTK ANTIBODIES FOR TREATING CANCER
Application WO-2020076799-A1
World Intellectual Property Organisation (WIPO)
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
Grant US-10618967-B2
United States of America
Methods for treating neurodegenerative disease using anti-PD-1 antibodies
Grant US-10618955-B2
United States of America
Antibodies and immunocytokines
Grant US-10604576-B2
United States of America
Methods for treating hematologic cancers
Grant US-10570204-B2
United States of America
Method of treating cancer using immune checkpoint inhibitor
Grant US-10544224-B2
United States of America
Anti-PD-L1 antibodies and their use as therapeutics and diagnostics
Grant US-10544225-B2
United States of America
ANTI-PD-1 ANTIBODY
Application EP-3498839-A4
European Patent Office
Anti-PD1 antibodies and their use as therapeutics and diagnostics
Grant US-10519235-B2
United States of America
Compositions comprising a combination of nivolumab and ipilimumab
Application US-10512689-B2
United States of America
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof
Application US-10513558-B2
United States of America
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-10479833-B2
United States of America
Antibody molecules to TIM-3 and uses thereof
Grant US-10472419-B2
United States of America
Anti-PD-1 antibodies and methods of use thereof
Grant US-10450373-B2
United States of America
ANTI-CD27 ANTIBODIES AND USES THEREOF
Application WO-2019195452-A1
World Intellectual Property Organisation (WIPO)
IMPROVED INTERFERON THERAPY
Application EP-3416727-A4
European Patent Office
Anti-PD-L1 antibodies
Grant US-10435470-B2
United States of America
Anti PD-1 antibodies
Grant US-10428146-B2
United States of America
Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
Grant US-10415015-B2
United States of America
Tumor antigen specific antibodies and TLR3 stimulation to enhance the performance of…
Application US-10392444-B2
United States of America
Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
Grant US-10392442-B2
United States of America
SELECTIVE BCL-2 INHIBITORS IN COMBINATION WITH AN ANTI-PD-1 OR AN ANTI-PD-L1 ANTIBODY FOR…
Application WO-2019161221-A2
World Intellectual Property Organisation (WIPO)
ANTI-PD-1 ANTIBODIES AND USES THEREOF
Application EP-3328895-A4
European Patent Office
Combination therapies of HDAC inhibitors and PD-1 inhibitors
Grant US-10385130-B2
United States of America
Combination therapies of HDAC inhibitors and PD-L1 inhibitors
Grant US-10385131-B2
United States of America
PD-1 ANTIBODIES
Application EP-3411410-A4
European Patent Office
PD-1 ANTIBODIES
Application EP-3383915-A4
European Patent Office
Anti-PD-1 antibodies and methods of use thereof
Grant US-10323091-B2
United States of America
PD-1 antibodies
Application US-10316089-B2
United States of America
Anti-human PD-1 humanized monoclonal antibody and application
Application JP-2019514355-A
Japan
Combination therapies of HDAC inhibitors and PD-1 inhibitors
Grant US-10287353-B2
United States of America
Anti-PD-1 antibodies
Application US-10280224-B2
United States of America
COMBINATION ANTI-CSF1R AND ANTI-PD-1 ANTIBODY COMBINATION THERAPY FOR PANCREATIC CANCER
Application WO-2019055537-A1
World Intellectual Property Organisation (WIPO)
ANTIBODIES TO PROGRAMMED CELL DEATH PROTEIN 1
Application WO-2019051164-A1
World Intellectual Property Organisation (WIPO)
Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer
Grant US-10221244-B2
United States of America
Treatment of PD-L1-negative melanoma using an anti-PD-1 antibody and an anti-CTLA-4…
Application US-10174113-B2
United States of America
Treatment of cancer using anti-TGF-BETA and PD-1 antibodies
Grant US-10167334-B2
United States of America
ANTI-PD-1 ANTIBODIES
Application WO-2018087143-A3
World Intellectual Property Organisation (WIPO)
Anti-CTLA-4 antibodies and methods of use thereof
Grant US-10144779-B2
United States of America
DESIGN OF THERAPEUTIC IMMUNOGLOBULIN G4 FOR IMPROVED BIOANALYTICAL AND BIOPROCESSING…
Application WO-2018119380-A2
World Intellectual Property Organisation (WIPO)
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
Application WO-2018107004-A1
World Intellectual Property Organisation (WIPO)
Anti-PD1 antibodies and their use as therapeutics and diagnostics
Grant US-9988450-B2
United States of America
ANTI-PD-1 ANTIBODIES
Application EP-3212671-A4
European Patent Office
METHODS OF TREATING UROTHELIAL CARCINOMA USING AN ANTI-PD-1 ANTIBODY
Application WO-2018081621-A1
World Intellectual Property Organisation (WIPO)
PD-1 ANTIBODIES
Application WO-2018068336-A1
World Intellectual Property Organisation (WIPO)
Antibody molecules to LAG-3 and uses thereof
Grant US-9908936-B2
United States of America
Antibody molecules to TIM-3 and uses thereof
Grant US-9884913-B2
United States of America
ANTI-PD-L1 AND IL-2 CYTOKINES
Application WO-2017220989-A1
World Intellectual Property Organisation (WIPO)
ANTI-PD-L1 ANTIBODIES
Application WO-2017220990-A1
World Intellectual Property Organisation (WIPO)
USE OF ANTI-PD-1 ANTIBODY IN THE TREATMENT OF PATIENTS WITH COLORECTAL CANCER
Application WO-2017210637-A1
World Intellectual Property Organisation (WIPO)
PD-1 BLOCKADE WITH NIVOLUMAB IN REFRACTORY HODGKIN'S LYMPHOMA
Application WO-2017210453-A1
World Intellectual Property Organisation (WIPO)
ANTI-PD-1 ANTIBODY FOR USE IN A METHOD OF TREATMENT OF RECURRENT SMALL CELL LUNG CANCER
Application WO-2017210631-A1
World Intellectual Property Organisation (WIPO)
Anti-PD1 antibodies and their use as therapeutics and diagnostics
Grant US-9834606-B2
United States of America
Antibody molecules to PD-1 and uses thereof
Grant US-9815898-B2
United States of America
Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer
Grant US-9765147-B2
United States of America
Antibody molecules to PD-1 and uses thereof
Grant US-9683048-B2
United States of America
PD-1 specific antibodies and uses thereof
Grant US-9683043-B2
United States of America
ANTI-PD-1 ANTIBODIES AND COMPOSITIONS
Application WO-2017055547-A1
World Intellectual Property Organisation (WIPO)
Antibody molecules to TIM-3 and uses thereof
Grant US-9605070-B2
United States of America
METHOD OF TREATING CANCER USING IMMUNE CHECKPOINT INHIBITOR
Application WO-2017011666-A1
World Intellectual Property Organisation (WIPO)
TREATMENT OF CANCER BY COMBINED BLOCKADE OF THE PD-1 AND CXCR4 SIGNALING PATHWAYS
Application WO-2016201425-A1
World Intellectual Property Organisation (WIPO)
TREATMENT OF PD-L1 POSITIVE LUNG CANCER USING AN ANTI-PD-1 ANTIBODY
Application WO-2016191751-A1
World Intellectual Property Organisation (WIPO)
Showing items 101–200